stemcellsinc.com
StemCells, Inc. - Clinical Programs: Our Clinical Approach
http://www.stemcellsinc.com/Clinical-Programs/SCI
Spinal Cord Injury (SCI). Age-related Macular Degeneration (AMD). Neuronal Ceroid Lipofuscinosis (NCL). Spinal Cord Injury: Clinical Program. Phase II Trial in Cervical Spinal Cord Injury (SCI). Learn more about the six-month interim results from Cohort 1 of the Pathway Study…. Learn more about ongoing enrollment in the Pathway Study…. Phase I/II Trial in Thoracic SCI. Enrollment in this study, which transplanted patients with T2-T11 thoracic spinal cord injury, was completed in May 2014. Top-line re...
stemcellsinc.com
StemCells, Inc. : Groundbreaking Science. Breakthrough Medicine.
http://www.stemcellsinc.com/Home
Is engaged in clinical development of its proprietary HuCNS-SC. Purified human neural stem cells) platform technology to treat disorders of the central nervous system (CNS). Learn more…. Spinal cord injury (SCI) is the second leading cause of paralysis in the U.S. Transplantation of HuCNS-SC. Cells holds much promise. Learn more…. StemCells, Inc. has been very professional. They have given me all the support that I need. ”. Mdash; Phase I/II SCI Clinical Trial Patient. Read the article…. Martin McGlynn a...
stemcellsinc.com
StemCells, Inc. - Therapeutic Programs: Spinal Cord Injury
http://www.stemcellsinc.com/Science/Pre-Clinical-Studies/Spinal-Cord-Injury
The Promise of Stem Cells. Spinal Cord Injury (SCI): Pre‑clinical Studies. Published pre-clinical data demonstrates the therapeutic potential of the StemCells HuCNS-SC. Purified human neural stem cells) platform technology to treat spinal cord injury (SCI). Human neural stem cells promote long-term functional motor recovery. Learn more…. Download PDF of published research; see page 3, Figure A…. Open Field BBB Score (0-18). DT treatment to ablate transplanted cells. Restored motor function lost. Human ne...